epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions
ProfileSign in

The clinical information you need, at your fingertips.

Medical News for You

Government Health Agency News

Health Canada

1m

Generic semaglutide injection wins approval in Canada amid expanding GLP‑1 market

The approval opens the door to lower‑cost, once‑weekly semaglutide therapy for adults with type 2 diabetes without changing clinical expectations for safety or efficacy. . .

Journal Article Synopsis

SSRS survey

1h

Many women miss guidance to start mammograms at 40

Nearly half of U.S. women surveyed believed annual mammograms should start at age 50, despite radiology-focused groups recommending yearly screening beginning at age 40. . .

Journal Article Synopsis

Clin Gastroenterol Hepatol

2h

Hemorrhoids guidance shifts focus to fiber, toilet habits over quick fixes

Simple lifestyle changes lead new AGA advice on a common condition. . .

Journal Article Synopsis

Neurology

2h

Choice of first antiseizure drug may influence survival in dementia-related epilepsy

Registry study links initial antiseizure med choice to meaningful differences in mortality among patients with dementia and epilepsy. . .

Journal Article Synopsis

Ann Rheum Dis

3h

Move more, sit less: EULAR updates physical activity guidance for arthritis care

Physical activity becomes standard care across inflammatory arthritis and osteoarthritis. . .

Journal Article Synopsis

JAMA Netw Open

3h

Drugs risky for cognition linger after acute elder care

Older adults, especially those with dementia, often continued medications that can impair cognition a year after they were started. Many prescriptions began in acute or post-acute care settings. . .

Journal Article Synopsis

Nat Commun

4h

AI facial aging tool predicts cancer survival

Serial face photos analyzed by artificial intelligence showed that faster facial aging was associated with worse survival in patients receiving cancer treatment. . .

Internally Generated Content

Drug pipeline

4h

Late‑stage trial supports gene editing strategy for hereditary angioedema

In a phase 3 trial, a single infusion reduced monthly swelling episodes by 87% vs. placebo. . .

Journal Article Synopsis

JAMA Netw Open

5h

Switching DOACs after breakthrough stroke shows no short‑term advantage

At 90 days, recurrent stroke and major bleeding rates were similar whether patients stayed on the same DOAC or switched. . .

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information